Compare MasTec Inc (MTZ) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Recursion Pharmaceuticals Inc — how do they compare? MasTec Inc trades at $351.51 (market cap $26.60B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: MasTec Inc is far larger — about 17.4× Recursion Pharmaceuticals Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| MTZ | RXRX | |
|---|---|---|
Market Cap | $26.60B | $1.53B |
Sector | Technology | Health |
52-Week High | $437.51 | $6.79 |
52-Week Low | $172.51 | $2.84 |
Enterprise Value | $29.34B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
